97 related articles for article (PubMed ID: 18580099)
1. Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology.
Chetty R; Serra S
Adv Anat Pathol; 2008 Jul; 15(4):234-40. PubMed ID: 18580099
[TBL] [Abstract][Full Text] [Related]
2. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.
Chetty R; Serra S
Histopathology; 2008 Feb; 52(3):325-30. PubMed ID: 18269583
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
[TBL] [Abstract][Full Text] [Related]
4. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
9. Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas.
Serra S; Chetty R
J Clin Pathol; 2008 Nov; 61(11):1153-9. PubMed ID: 18708424
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
[TBL] [Abstract][Full Text] [Related]
11. Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis.
Lopes FF; da Costa Miguel MC; Pereira AL; da Cruz MC; de Almeida Freitas R; Pinto LP; de Souza LB
Ann Diagn Pathol; 2009 Feb; 13(1):22-9. PubMed ID: 19118778
[TBL] [Abstract][Full Text] [Related]
12. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
14. p120 catenin reduction and cytoplasmic relocalization leads to dysregulation of E-cadherin in solid pseudopapillary tumors of the pancreas.
Chetty R; Jain D; Serra S
Am J Clin Pathol; 2008 Jul; 130(1):71-6. PubMed ID: 18550473
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
Dilek FH; Topak N; Aktepe F; Sahin O; Türel KS; Sahin DA; Dilek ON
Pathol Res Pract; 2008; 204(11):809-15. PubMed ID: 18674869
[TBL] [Abstract][Full Text] [Related]
16. Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis.
Geers C; Moulin P; Gigot JF; Weynand B; Deprez P; Rahier J; Sempoux C
Am J Surg Pathol; 2006 Oct; 30(10):1243-9. PubMed ID: 17001154
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, beta-catenin and APC protein in canine colorectal tumours.
Restucci B; Martano M; DE Vico G; Lo Muzio L; Maiolino P
Anticancer Res; 2009 Aug; 29(8):2919-25. PubMed ID: 19661296
[TBL] [Abstract][Full Text] [Related]
19. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
